CVE-2020-37014Tryton 5.4 - Persistent Cross-Site Scripting
Updated under an hour ago ()
Does this affect you?
It affects Tryton. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Tryton 5.4 contains a persistent cross-site scripting vulnerability in the user profile name input that allows remote attackers to inject malicious scripts. Attackers can exploit the vulnerability by inserting script payloads in the name field, which execute in the frontend and backend user interfaces.
- CVSS
- 6.4 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:N
- Weakness (CWE)
- CWE-79
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- VulnCheck
- NVD analysis
- Deferred
- Record last updated
- May 13, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Tryton Tryton tryton:tryton (from the name) | through 5.4 | CNA record |
References
- https://www.exploit-db.com/exploits/48466exploit
- https://www.tryton.org/product
- https://www.tryton.org/downloadproduct
- https://www.vulnerability-lab.com/get_content.php?id=2233third-party-advisory
- https://www.vulncheck.com/advisories/tryton-persistent-cross-site-scriptingthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.